Neurology· Topic 10.8 Central nervous system infections· 10.8.13

HIV-associated neurocognitive disorders

HIV-associated neurocognitive disorders (HAND) span a spectrum from asymptomatic neurocognitive impairment to HIV-associated dementia, caused by chronic HIV infection and inflammation of CNS microglia, and occur regardless of antiretroviral treatment status; diagnosis is one of exclusion after ruling out opportunistic and metabolic causes of cognitive decline, and antiretroviral therapy initiation or optimization is the primary treatment, with efavirenz avoided for its neuropsychiatric effects.

13 min read3 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    HIV-associated neurocognitive disorders (HAND) is a spectrum of cognitive impairment caused by HIV infection of the central nervous system, ranging from asymptomatic neurocognitive impairment through…

  • Epidemiology

    Screening for cognitive impairment is recommended at entry into HIV care as a baseline against which later decline can be measured, and repeated in older adults, especially when concerns arise about adherence to care or ART.

  • Risk factors

    Chronic HIV infection itself, through ongoing low-grade CNS viral reservoir activity and microglial infection, independent of systemic virologic suppression.

  • Pathophysiology

    HIV enters the central nervous system early in infection via infected monocytes and lymphocytes that cross the blood-brain barrier, establishing infection of resident microglia and, to a lesser…

  • Clinical features

    Cognitive impairment ranging from subtle, subclinical deficits detectable only on formal neuropsychological testing to overt functional impairment in daily activities, reflecting the breadth of the…

  • Differential diagnosis

    CNS toxoplasmosis: headache, fever, and focal deficits with multiple ring-enhancing lesions on CT or MRI in a patient with a CD4 cell count under 100/microliter and positive Toxoplasma serology…

  • Diagnosis

    HIV-associated neurocognitive disorders is a diagnosis of exclusion, established only after ruling out opportunistic CNS infection, CNS malignancy, and other systemic, metabolic, substance-related…

  • Management

    First, if the patient is not already on antiretroviral therapy (ART), start it immediately with a standard three-drug regimen, for example bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide…

  • Complications

    Progression from milder cognitive impairment to HIV-associated dementia if untreated or if uncontrolled viral replication persists.

  • Prognosis

    ART is central to prognosis: initiation or optimization has a clear role in preventing progression to, and improving outcomes in, HIV-associated dementia.

  • Prevention

    Early diagnosis and prompt initiation of ART at the time of HIV diagnosis is the principal preventive strategy, limiting the duration and depth of CNS viral injury before treatment begins.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.